What medications are used to treat constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Constipation

Start with polyethylene glycol (PEG) 17 g daily as first-line therapy for chronic constipation, as it is the most effective, cost-efficient, and well-tolerated option with proven long-term safety. 1, 2

First-Line Treatment: Osmotic Laxatives

Polyethylene Glycol (PEG) - Gold Standard

  • PEG 17 g daily is the preferred initial treatment based on superior efficacy, safety profile, and cost-effectiveness ($10-$45/month) 1, 2
  • Take once daily on an empty stomach, at least 30 minutes before a meal 3
  • Titrate dose based on symptom response and side effects with no clear maximum dose 1, 2
  • Response is durable over 6-12 months of continuous use 1, 4, 5
  • Common side effects include bloating, abdominal discomfort, and cramping 1
  • Ensure adequate hydration while using PEG 1

Alternative Osmotic Laxatives

  • Magnesium oxide 400-500 mg daily can be used as an alternative, but use with caution in renal insufficiency and pregnancy 1
  • Lactulose 15 g daily is another option and is the only osmotic agent studied in pregnancy, though bloating and flatulence may be limiting 1
  • Meta-analysis shows PEG is superior to lactulose for stool frequency, stool form, and relief of abdominal pain 6

Fiber Supplementation

  • 14 g fiber per 1,000 kcal daily intake can be added as adjunctive therapy 1
  • Ensure adequate hydration as fiber intake increases 1
  • Common side effects include bloating and abdominal discomfort 1

Second-Line Treatment: Stimulant Laxatives

Use stimulant laxatives for short-term use or rescue therapy when osmotic laxatives provide inadequate response. 1, 2

  • Bisacodyl 5 mg daily (maximum 10 mg daily) is recommended for short-term use 1, 2
  • Senna 8.6-17.2 mg daily (maximum 4 tablets twice daily) can be used, but long-term safety and efficacy are unknown 1, 2
  • Both agents are recommended for short-term use or rescue therapy due to potential for cramping, abdominal discomfort, and electrolyte imbalance with prolonged use 1

Third-Line Treatment: Prescription Secretagogues

For refractory cases not responding to osmotic and stimulant laxatives, consider prescription secretagogues. 1, 2

Intestinal Secretagogues

  • Lubiprostone 24 mcg twice daily acts on chloride channel type 2 in the gut and may provide additional benefit for abdominal pain ($374/month) 1, 2
  • Linaclotide 72-145 mcg daily (maximum 290 mcg daily) is a guanylate cyclase-C agonist that may benefit abdominal pain ($523/month) 1, 2, 3
  • Plecanatide 3 mg daily (no titration needed) is another guanylate cyclase-C agonist option ($526/month) 1, 2, 7
  • Diarrhea may occur in a subset of patients with all secretagogues, leading to discontinuation 1

Prokinetic Agent

  • Prucalopride 1-2 mg daily (maximum 2 mg daily) is a serotonin type 4 (5-HT4) receptor agonist that enhances colonic motility and may provide additional benefit for abdominal pain ($563/month) 1, 2
  • Headaches and diarrhea may occur in some patients 1

Treatment Algorithm

  1. Start with PEG 17 g daily as the most cost-effective option with best evidence for long-term use 1, 2
  2. If inadequate response after 2-3 days, titrate PEG dose upward based on clinical response 2, 8
  3. If PEG alone fails, add or switch to stimulant laxatives (bisacodyl or senna) for short-term use 1, 2
  4. For refractory cases, consider prescription secretagogues (lubiprostone, linaclotide, plecanatide) or prokinetic agent (prucalopride) 1, 2

Critical Safety Warnings

  • Do not give linaclotide to children less than 2 years of age - it can cause severe diarrhea and dehydration 3
  • Do not give plecanatide to children less than 6 years of age - it may cause severe diarrhea and dehydration 7
  • Do not use any laxatives in patients with bowel obstruction 3, 7
  • Store secretagogue medications securely out of reach of children due to risk of severe diarrhea if accidentally ingested 3, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Chronic Constipation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lactulose versus Polyethylene Glycol for Chronic Constipation.

The Cochrane database of systematic reviews, 2010

Guideline

Recommended Dosage of PEG for IBS-C

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.